Search

everythinglearnresearchcommunity

for

Search:↓

Cases of alopecia areata and its impact on life quality rose globally, but when adjusted for age, the rates decreased, especially in poorer regions.

Alopecia areata cases in children are rising, especially in females and low-income regions, with a projected increase in China and decrease in the USA.

Skin has a larger surface area than thought, certain skin cells improve skin flap survival, better trials for skin conditions in children are needed, Stevens-Johnson syndrome rates vary by age and race, and better skin barrier function may reduce inflammation in the elderly.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Alopecia Areata affects young adults more in high-income countries, especially females.

Alopecia areata cases have increased globally, affecting mostly women aged 30-34, with links to other health issues.

Orbital decompression surgery for Graves' orbitopathy caused double vision in 19% of patients, with similar rates for two surgical methods.

B6J mice live longer before 24 months, but B6N mice live longer after; both strains show weight gain, increased food and water intake, and health issues as they age.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

PCOS is common, affects hormones, and often diagnosed late, impacting women's quality of life.

Alopecia areata is increasing globally, with disparities needing better prevention and support.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

High doses of cyproterone acetate are linked to an increased risk of developing meningioma.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Estrogen and androgenic hair increase melanoma risk, especially in European-ancestry individuals.

Oral minoxidil users, especially for hypertension, may risk heart issues, and better monitoring guidelines are needed for alopecia patients.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Finasteride use may increase the risk of male breast cancer.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Untreated androgenetic alopecia leads to progressive hair loss in men.

Children's hair grows in different types from before birth through puberty, with growth rates and characteristics varying by age, sex, and race.

DHT may increase the risk of heart disease and death in elderly men.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Pharmacists play a crucial role in customizing treatments and ensuring medication safety.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.